The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 42,202,440 | 2,317,542 | SH | SOLE | 2,317,542 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 12,403,319 | 232,446 | SH | SOLE | 232,446 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 1,520,050 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 3,431,022 | 189,350 | SH | SOLE | 189,350 | 0 | 0 | |||
| AURA BIOSCIENCES INC | COM | 05153U107 | 3,584,326 | 572,576 | SH | SOLE | 572,576 | 0 | 0 | |||
| CELLECTIS S A | SPON ADS | 15117K103 | 4,966,164 | 3,256,501 | SH | SOLE | 3,256,501 | 0 | 0 | |||
| ELI LILLY & CO | PUT | 532457958 | 11,692,950 | 15,000 | SH | Put | SOLE | 15,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 15,599,200 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,580,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 840,750 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 1,471,750 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
| SIGHT SCIENCES INC | COM | 82657M105 | 3,840,900 | 930,000 | SH | SOLE | 930,000 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 1,197,600 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 4,159,284 | 1,800,556 | SH | SOLE | 1,800,556 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 3,999,600 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | CALL | 90400D908 | 2,457,936 | 67,600 | SH | Call | SOLE | 67,600 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 13,988,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||